Preliminary Clinical and Pharmacologic Investigation of Photodynamic Therapy with the Silicon Phthalocyanine Photosensitizer Pc 4 for Primary or Metastatic Cutaneous Cancers

Photodynamic therapy (PDT) for cutaneous malignancies has been found to be an effective treatment with a range of photosensitizers. The phthalocyanine Pc 4 was developed initially for PDT of primary or metastatic cancers in the skin. A Phase I trial was initiated to evaluate the safety and pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinsella, Timothy James, Baron, Elma D., Colussi, Valdir C., Cooper, Kevin D., Hoppel, Charles L., Ingalls, Stephen T., Kenney, Malcolm E., Li, Xiaolin, Oleinick, Nancy L., Stevens, Seth R., Remick, Scot C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355859/
https://www.ncbi.nlm.nih.gov/pubmed/22649754
http://dx.doi.org/10.3389/fonc.2011.00014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355859/
https://www.ncbi.nlm.nih.gov/pubmed/22649754
http://dx.doi.org/10.3389/fonc.2011.00014

Ejemplares similares